Autopsy report · NCT00697255
A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)
Cause of deathNo reason given
Life of this trial
- Registered 1 year 1 month after it had already started.
- Ran for about 1 year before it stopped.
- 8 participants enrolled.
- Results were posted on the registry 6 years 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Organon and Co
- Sponsor type
- Industry
- Conditions
- Ovulation Induction
- Interventions
- corifollitropin alfa; recombinant Follicle Stimulating Hormone (recFSH); human Chorion Gonadotropin (hCG); hCG Bolus injection
- Participants
- 8
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.